Sign in

CIK 0001393434

  • Large accelerated filer

OCULAR THERAPEUTIX, INC

Sign in to watch
Ticker
OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-357-4000
Business address
14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
Former names
I-THERAPEUTIX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$799,174
in 9 filings, $788K under 10b5-1 plans

Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-16 Heier Jeffrey S. Director Grant or award · Stock Option (Right to Buy) +26,800 26,800
2022-05-12 LINDSTROM RICHARD L MD Director Exercise or conversion +9,469 $1.22 $12K 99,469
2022-05-12 LINDSTROM RICHARD L MD Director Exercise or conversion · Stock Option (Right to Buy) −9,469 0
2022-05-12 Heier Jeffrey S. Director Purchase +15,000 $3.05 $46K 39,000
2022-02-23 SUMMER ROAD LLC 10% owner Purchase +10,000 $4.80 $48K 5,944,761
2022-02-18 SUMMER ROAD LLC 10% owner Purchase +40,000 $5.00 $200K 5,934,761
2022-02-03 Notman Donald Chief Financial Officer Grant or award +55,556 81,632
2022-02-03 Notman Donald Chief Financial Officer Grant or award · Stock Option (Right to Buy) +166,667 166,667
2022-02-03 Strassburger Philip C. General Counsel Grant or award +50,000 51,810
2022-02-03 Strassburger Philip C. General Counsel Grant or award · Stock Option (Right to Buy) +150,000 150,000
2022-02-03 White Christopher G Chief Business Officer Grant or award +50,000 52,127
2022-02-03 White Christopher G Chief Business Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2022-02-03 Goldstein Michael H. President, Ophthalmology & CMO Grant or award +63,333 313,335
2022-02-03 Goldstein Michael H. President, Ophthalmology & CMO Grant or award · Stock Option (Right to Buy) +190,000 190,000
2022-02-03 Mattessich Antony C. President and CEO Grant or award +186,750 289,650
2022-02-03 Mattessich Antony C. President and CEO Grant or award · Stock Option (Right to Buy) +560,200 560,200
2022-01-28 SUMMER ROAD LLC 10% owner Purchase +4,023 $5.20 $21K 5,894,761
2022-01-27 SUMMER ROAD LLC 10% owner Purchase +1,477 $5.20 $8K 5,890,738
2022-01-24 SUMMER ROAD LLC 10% owner Purchase +44,400 $5.31 $236K 5,889,261
2022-01-21 SUMMER ROAD LLC 10% owner Purchase +12,152 $5.56 $68K 5,844,861

Page 13 of 17 · 327 trades